Baker Bros Boosts Its KYMR, REPL Stakes

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes in a 13G filing by Baker Bros Advisors LP.

The hedge fund increased its ownership position in Kymera Therapeutics Inc $KYMR from 9.2% to 10.8%.

Baker Bros filed another 13G, this one for Replimune Group Inc $REPL revealing an increase in its stake by 6.5%.

Here’s The Hot Corner, with data through January 10, 2024:

The CEO of Walgreens Boots Alliance $WBA revealed an additional purchase of $242,220 in its latest Form 4.

Cathie Wood’s infamous ARK Investment Management filed a 13G for CRISPR Therapeutics AG $CRSP, revealing an increase in its ownership stake from 10.05% to 10.75%.

In the options market, there was bullish flow in Southwest Airlines Co $LUV, Pinterest Inc $PINS, Rocket Companies Inc $RKT, and Avantor Inc $AVTR.

Stay tuned. We’ll be back on Friday with more insider activity.

If you want these insider transactions e-mailed to you every morning, click here to sign up for The Hot Corner.

And please reach out with any questions. We love hearing from you!

All Star Charts Team

Source link

Be the first to comment

Leave a Reply

Your email address will not be published.